Silverback Therapeutics
(NASDAQ:SBTX)
4.29
-0.15[-3.38%]
At close: Jun 28
4.32
0.0300[0.70%]
After Hours: 4:28PM EDT
Day High/Low4.11 - 4.48
52 Week High/Low2.8 - 35.63
Open / Close4.44 / 4.29
Float / Outstanding20.7M / 35.1M
Vol / Avg.649.2K / 480.6K
Mkt Cap150.8M
P/E-
50d Avg. Price3.49
Div / Yield-
Payout Ratio-
EPS-0.7
Total Float20.7M

Silverback Therapeutics (NASDAQ:SBTX), Quotes and News Summary

Silverback Therapeutics (NASDAQ: SBTX)

Day High/Low4.11 - 4.48
52 Week High/Low2.8 - 35.63
Open / Close4.44 / 4.29
Float / Outstanding20.7M / 35.1M
Vol / Avg.649.2K / 480.6K
Mkt Cap150.8M
P/E-
50d Avg. Price3.49
Div / Yield-
Payout Ratio-
EPS-0.7
Total Float20.7M
load more
Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Silverback Therapeutics Questions & Answers

Q
How do I buy Silverback Therapeutics (SBTX) stock?
A

You can purchase shares of Silverback Therapeutics (NASDAQ: SBTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Silverback Therapeutics's (SBTX) competitors?
A

There are no as such competitors for Silverback Therapeutics.

Q
What is the target price for Silverback Therapeutics (SBTX) stock?
A

The latest price target for Silverback Therapeutics (NASDAQ: SBTX) was reported by Goldman Sachs on Monday, April 4, 2022. The analyst firm set a price target for 3.50 expecting SBTX to fall to within 12 months (a possible -18.41% downside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Silverback Therapeutics (SBTX)?
A

The stock price for Silverback Therapeutics (NASDAQ: SBTX) is $4.29 last updated June 28, 2022, 8:00 PM UTC.

Q
Does Silverback Therapeutics (SBTX) pay a dividend?
A

There are no upcoming dividends for Silverback Therapeutics.

Q
When is Silverback Therapeutics (NASDAQ:SBTX) reporting earnings?
A

Silverback Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Silverback Therapeutics (SBTX) going to split?
A

There is no upcoming split for Silverback Therapeutics.

Q
What sector and industry does Silverback Therapeutics (SBTX) operate in?
A

Silverback Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.